tiprankstipranks
Trending News
More News >
RegenXBio (RGNX)
NASDAQ:RGNX

Compare RegenXBio (RGNX) vs. Competitors

Compare
1,018 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RegenXBio
$15.00
$759.35M
-4.30
80.94%
7 Buy
0 Hold
0 Sell
Strong Buy
Solid Biosciences
$5.31
$413.70M
-2.13
31.76%
10 Buy
0 Hold
0 Sell
Strong Buy
Monopar Therapeutics Inc
$63.40
$423.68M
159.20%
11 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$25.31
$1.65B
82.87
322.54%
8 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.09B
-7.35
402.00%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RGNX
RegenXBio
15.00
8.05
115.83%
SLDB
Solid Biosciences
5.31
2.00
60.42%
MNPR
Monopar Therapeutics Inc
63.40
37.71
146.79%
OPT
GLUE
Monte Rosa Therapeutics
25.31
19.65
347.17%
INBX
Inhibrx Biosciences Inc
75.20
61.56
451.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts